Gene therapy hope for severe Parkinson's patients
Disease control
Recruiting now
This early-stage trial tests a gene therapy called IPS101A in 6 people with advanced Parkinson's disease (stages 4-5) whose symptoms are not well-controlled by current medications. The main goal is to check safety and find the best dose, while also looking for any signs of improv…
Phase: PHASE1 • Sponsor: Innopeutics Corporation • Aim: Disease control
Last updated May 09, 2026 14:28 UTC